Laboratoire de Biologie Structurale de la Cellule (CNRS UMR7654), Ecole Polytechnique, Institut Polytechnique de Paris, Palaiseau, France.
Protein Sci. 2023 Sep;32(9):e4738. doi: 10.1002/pro.4738.
Amino acids (AAs) with a noncanonical backbone would be a valuable tool for protein engineering, enabling new structural motifs and building blocks. To incorporate them into an expanded genetic code, the first, key step is to obtain an appropriate aminoacyl-tRNA synthetase. Currently, directed evolution is not available to optimize AAs with noncanonical backbones, since an appropriate selective pressure has not been discovered. Computational protein design (CPD) is an alternative. We used a new CPD method to redesign MetRS and increase its activity towards β-Met, which has an extra backbone methylene. The new method considered a few active site positions for design and used a Monte Carlo exploration of the corresponding sequence space. During the exploration, a bias energy was adaptively learned, such that the free energy landscape of the apo enzyme was flattened. Enzyme variants could then be sampled, in the presence of the ligand and the bias energy, according to their β-Met binding affinities. Eighteen predicted variants were chosen for experimental testing; 10 exhibited detectable activity for β-Met adenylation. Top predicted hits were characterized experimentally in detail. Dissociation constants, catalytic rates, and Michaelis constants for both α-Met and β-Met were measured. The best mutant retained a preference for α-Met over β-Met; however, the preference was reduced, compared to the wildtype, by a factor of 29. For this mutant, high resolution crystal structures were obtained in complex with both α-Met and β-Met, indicating that the predicted, active conformation of β-Met in the active site was retained.
具有非经典骨架的氨基酸(AAs)将是蛋白质工程的宝贵工具,能够构建新的结构基序和构建块。为了将它们纳入扩展的遗传密码,第一步也是关键的一步是获得合适的氨酰-tRNA 合成酶。目前,由于尚未发现适当的选择压力,定向进化无法用于优化具有非经典骨架的氨基酸。计算蛋白质设计(CPD)是一种替代方法。我们使用一种新的 CPD 方法重新设计 MetRS,以提高其对β-Met 的活性,β-Met 具有额外的骨架亚甲基。新方法考虑了几个设计的活性位点,并使用蒙特卡罗方法对相应的序列空间进行了探索。在探索过程中,适应性地学习了偏置能,从而使脱辅基酶的自由能景观变平。然后可以根据配体和偏置能,根据它们与β-Met 的结合亲和力对酶变体进行采样。选择了 18 个预测变体进行实验测试;其中 10 个对β-Met 腺苷酸化表现出可检测的活性。对预测的顶级命中物进行了详细的实验表征。测定了α-Met 和β-Met 的解离常数、催化速率和米氏常数。最佳突变体对α-Met 的偏好仍保留,但与野生型相比,偏好度降低了 29 倍。对于该突变体,获得了与α-Met 和β-Met 复合物的高分辨率晶体结构,表明预测的β-Met 在活性位点的活性构象得以保留。